chloroquine has been researched along with Polycystic Ovarian Syndrome in 1 studies
Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Kobayashi, M | 1 |
Yoshino, O | 1 |
Nakashima, A | 1 |
Ito, M | 1 |
Nishio, K | 1 |
Ono, Y | 1 |
Kusabiraki, T | 1 |
Kunitomi, C | 1 |
Takahashi, N | 1 |
Harada, M | 1 |
Hattori, K | 1 |
Orisaka, M | 1 |
Osuga, Y | 1 |
Saito, S | 1 |
1 other study available for chloroquine and Polycystic Ovarian Syndrome
Article | Year |
---|---|
Inhibition of autophagy in theca cells induces CYP17A1 and PAI-1 expression via ROS/p38 and JNK signalling during the development of polycystic ovary syndrome.
Topics: Adult; Animals; Autophagy; Cattle; Chloroquine; Female; Humans; MAP Kinase Signaling System; Mitocho | 2020 |